Prot #R668-AD-1434: An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Dupilumab in Patients ≥6 Months to <18 Years of Age with Atopic Dermatitis

Project: Research project

Project Details

StatusActive
Effective start/end date2/23/182/23/21

Funding

  • ICON Clinical Research Limited (Prot #R668-AD-1434)
  • Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1434)